Predictive factors for resection and survival in type A borderline resectable pancreatic ductal adenocarcinoma patients after neoadjuvant therapy: A retrospective cohort study

Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, and surgical resection with radical intent remains the only potentially curative treatment option today. However, borderline resectable pancreatic ductal adenocarcinomas (BR-PDAC) stand in the gray area between the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Secanella, Luis, Busquets, Juli, Peláez, Núria, Sorribas, María, Laquente, Berta, Ruiz, Sandra, Carnaval, Thiago, Videla, Sebastián, Fabregat, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726357/
https://www.ncbi.nlm.nih.gov/pubmed/36482640
http://dx.doi.org/10.1097/MD.0000000000032126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726357/
https://www.ncbi.nlm.nih.gov/pubmed/36482640
http://dx.doi.org/10.1097/MD.0000000000032126

Ejemplares similares